The management of postnatal depression

Drug and Therapeutics Bulletin

Volumn 38, Issue 5, 2000, Pages 33-37

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN; FLUOXETINE;

CLINICAL FEATURE; COUNSELING; HORMONAL THERAPY; PUERPERAL DEPRESSION; RISK FACTOR; SHORT SURVEY;

EID: 0034023154     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2000.38533     Document Type: Short Survey

References (33)

1. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. Br J Psychiatry 1984; 144: 35-47.
2. Cooper PJ, Murray L. Course and recurrence of postnatal depression. Evidence for the specificity of the diagnostic concept. Br J Psychiatry 1995; 166. 191-5.
3. Cooper PJ, Murray L. The impact of psychological treatments of postpartum depression on maternal mood and infant developement. In: Murray L, Cooper PJ (Eds). Postpartum Depression and Child Development. New York: Guilford Press, 1997; 201-20.
4. Brockington I. Puerperal disorders. Adv Psychiatr Treat 1998; 4: 312-9.
5. Kennerley H, Gath D. Maternity blues I. Detection and measurement by questionnaire. Br J Psychiatry 1989; 155: 356-62.
6. O'Hara MW, Swain AM. Rates and risk of postpartum depression - a meta-analysis. Int Rev Psychiatry 1996; 8: 37-54.
7. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry 1993; 163: 27-31.
8. Murray L, Stanley C, Hooper R, King F, Fiori-Cowley A. The role of infant factors in postnatal depression and mother-infant interactions. Dev Med Child NeurOl 1996; 38: 109-19.
9. Harris B, Lovett L, Smith J, Read G, Walker R, Newcombe R. Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. Br J Psychiatry 1996; 168: 739-44
10. Harris B, Othman S, Davies JA et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ 1992; 305: 152-6.
11. Kumar RC. "Anybody's child": severe disorders of mother-to-infant bonding. Br J Psychiatry 1997; 171: 175-81.
12. Jennings KD, Ross S, Popper S, Elmore M. Thoughts of harming infents in depressed and nondepressed mothers. J Affect Disord 1999; 54: 21-8.
13. Murray L. The impact of postnatal depression on infant development. J Child Psychol Psychiatry 1992; 33: 543-61,
14. Sinclair D, Murray L. Effects of postnatal depression on children's adjustment to school Br J Psychiatry 1998, 172: 58-63.
15. Murray L, Sinclair D, Cooper P, Ducournau P, Turner P. The socioemotional development of 5-year-old children of postnatally depressed mothers. J Child Psychol Psychiatry 1999; 40: 1259-71.
16. Seeley S, Murray L, Cooper PJ. The outcomes for mothers and babies of health visitor intervention. Health Visit 1996; 69: 135-8.
17. Hearn G, Ilif A, Jones I et al. Postnatal depression in the community. Br J Gen Pract 1998; 48: 1064-6.
18. McIntosh J. Postpartum depression: women's help-seeking behaviour and perceptions of cause. J Adv Nurs 1993; 18: 178-84.
19. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-6.
20. Gerrard J, Holden JM, Elliott SA, McKenzie P, McKenzie J, Cox JL. A trainer's perspective of an innovative programme teaching health visitors about the detection, treatment and prevention of postnatal depression. J Adv Nurs 1993; 18: 1825-32.
21. Murray L, Carothers AD. The validation of the Edinburgh Postnatal Depression Scale on a community sample. Br J Psychiatry 1990; 157: 288-90.
22. Holden JM, Sagovsky R, Cox JL. Counselling in a general practice setting: controlled study of health visitor intervention in treatment of postnatal depression BMJ 1989; 298: 223-6.
23. Cohen LS, Rosenbaum JF. Psychotropic drug use during pregnancy: weighing the risks. J Clin Psychiatry 1998; 59 (suppl 2): 18-28
24. Nulman I, Rovet J, Stewart DE et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336: 258-62.
25. Wolman W-L, Chalmers B, Hofmeyr GJ, Nikodem VC. Postpartum depression and companionship in the clinical birth environment a randomized, controlled study. Am J Obstet Gynecol 1993; 168: 1388-93.
26. Nicolson P. Understanding postnatal depression: a mother-centred approach. J Adv Nurs 1990; 15: 689-95.
27. Wickberg B, Hwang CP. Counselling of postnatal depression: a controlled study on a population based Swedish sample. J Affect Disord 1996; 39. 209-16.
28. Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 1997; 314: 932-6.
29. Yoshida K, Smith B, Kumar R. Psychotropic drugs in mothers' milk: a comprehensive review of assay methods, pharmacokinetics and of safety of breast-feeding. J Psychopharmacol 1999; 13: 64-80.
30. Lawne TA, Herxheimer A, Dalton K. Oestrogens and progestogens for preventing and treating postnatal depression (Cochrane Review). In: The Cochrane Library, Issue 2, 2000. Oxford: Update Software.
31. Gregoire AJP, Kumar R, Everitt B, Henderson AF, Studd JWW. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347: 930-3.
32. Boath E, Cox J, Lewis M, Jones P, Pryce A. When the cradle falls: the treatment of postnatal depression in a psychiatric day hospital compared with routine primary care. J Affect Disord 1999; 53: 143-51.
33. The College. Report of the general psychiatry section working party on post-natal mental illness. Psychiatr Bull 1992; 16: 519-22.